Pelaia, G., Maselli, R. and Gallelli, L. (2014) “Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium”, Multidisciplinary Respiratory Medicine, 9(1). doi:10.4081/mrm.2014.399.